Clinical Trials Directory

Trials / Conditions / Alcohol-related Liver Disease

Alcohol-related Liver Disease

15 registered clinical trials studyying Alcohol-related Liver Disease — 10 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPeer Support for Liver Transplant Recipients With History of ALD
NCT07397598
Johns Hopkins UniversityN/A
RecruitingEnhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
NCT06269510
Henry Ford Health SystemN/A
Not Yet RecruitingA Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple B
NCT07087041
Beijing Friendship Hospital—
RecruitingInvestigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
NCT07060547
HepQuant, LLC—
Not Yet RecruitingGenetic Polymorphisms Associated With the Risk of Pancreatitis in Patients With Alcohol Related Cirrhosis.
NCT06763198
Institute of Liver and Biliary Sciences, India—
RecruitingImplementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
NCT06305624
University of Wisconsin, MadisonN/A
CompletedEffects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Us
NCT06409130
Novo Nordisk A/SPhase 2
RecruitingRisk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transpl
NCT06749990
IRCCS Azienda Ospedaliero-Universitaria di Bologna—
RecruitingStudy of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dys
NCT06403332
Hospital Universitari Vall d'Hebron Research InstituteN/A
UnknownContingency Management to Incentivise Treatment Adherence in Alcohol-related Liver Disease
NCT06183710
King's College Hospital NHS TrustN/A
RecruitingCHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
NCT05623150
Institut National de la Santé Et de la Recherche Médicale, France—
UnknownImpact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)
NCT04876443
King's College Hospital NHS Trust—
CompletedAcamprosate Safe to Use in Individuals With Liver Disease.
NCT04287920
Mayo ClinicPhase 2
Enrolling By InvitationInvestigating Myosteatosis in Steatotic Liver Diseases
NCT06514300
Cliniques universitaires Saint-Luc- Université Catholique de Louvain—
CompletedAlcohol Biomarkers in Post-Liver Transplant Patients
NCT01812226
Northwestern University—